These trials are thought to be a first step towards the development of more sophisticated nanobot technology, especially in fields like cancer treatment, where nanoparticles can be made to specifically target tumour cells. Researchers are also looking into different Conclusion To enhance the clinical ...
The findings were synthesized to present a coherent overview of how nanotechnology and nanobots are reshaping gynecological cancer management. The review highlights key innovations, current applications, and future directions for research and clinical implementation.The integration of nanotechnology and nano...
CancerDendrimers, liposomes, micelles, quantum dots, metallic or polymeric nanoshells, carbon nanotubes, nanowires, nanocantileversPoly(amino amine), poly(l-glutamic acid), poly(ethylene imine), poly(propylene imine), chitin, chitosan, RNA devices, poly(3,4-ethylenedioxy thiophene), poly(lactic ac...
[12], and phylogenetic differences; thus, the clinical application of EPO remains challenging. Targeted delivery using MNPs under magnetic navigation, which has been widely studied in cancer models [15,16,17], can be introduced as a solution. To prove the feasibility of ENBs (alginate-...